Learn About Glioblastoma

View Main Condition: Brain Tumor

What is the definition of Glioblastoma?
Glioblastoma is the most aggressive type of brain cancer. Glioblastoma develops from glial cells, which are specialized cells that surround and support neurons (nerve cells) in the brain.  Glioblastomas are classified as malignant Grade 4 tumors, meaning that they are rapidly reproducing and spreading.
What are the alternative names for Glioblastoma?
Glioblastoma may also be referred to as glioblastoma multiforme or GBM. 
What are the causes of Glioblastoma?
The causes of glioblastoma are not well defined. However, glioblastoma can rarely occur in individuals who have had previous radiation therapy, or individuals who have genetic conditions including neurofibromatosis and Li-Fraumeni syndrome.
What are the symptoms of Glioblastoma?
The symptoms of glioblastomas vary by location of the tumor. Common symptoms of glioblastoma include increased pressure in the brain, headaches, fatigue, nausea, vomiting, memory issues, and seizures. 
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Glioblastoma?
There is currently no cure for glioblastoma. Treatment depends on several factors including the size and location of the tumor, as well as the patient's overall health. Most treatment plans are palliative and designed based on an individual patient's unique situation. In general, treatment for glioblastoma may include surgery, radiation therapy, and/or chemotherapy. Surgery to remove as much of the tumor as possible is generally the first step in treating glioblastoma. However, if a tumor is located near a sensitive area in the brain, surgery may not be possible at all. Radiation therapy often follows surgery for the treatment of glioma. Radiation therapy involves the use of high-energy beams, including X-rays or protons, to destroy tumor cells. Chemotherapy involves the use of drugs, either taken orally or injected through a vein, to kill tumor cells. Chemotherapy is often used in combination with radiation therapy.
Who are the top Glioblastoma Local Doctors?
Glenn J. Lesser
Elite in Glioblastoma
Oncology | Hematology
Elite in Glioblastoma
Oncology | Hematology

Wake Forest University Health Sciences

Medical Ctr Blvd, 
Winston Salem, NC 
Languages Spoken:
English
Accepting New Patients

Glenn Lesser is an Oncologist and a Hematologist in Winston Salem, North Carolina. Dr. Lesser is rated as an Elite provider by MediFind in the treatment of Glioblastoma. His top areas of expertise are Brain Tumor, Glioblastoma, Astrocytoma, Glioma, and Bone Marrow Aspiration. Dr. Lesser is currently accepting new patients.

Elite in Glioblastoma
Elite in Glioblastoma

Ucsf Medical Group Business Services

521 Parnassus Ave, 
San Francisco, CA 
Languages Spoken:
English
Offers Telehealth

John De Groot is a Neurologist in San Francisco, California. Dr. De Groot is rated as an Elite provider by MediFind in the treatment of Glioblastoma. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Brain Tumor.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Glioblastoma
Elite in Glioblastoma

Trustees Of Columbia University In The City Of New York

622 W 168th St, 
New York, NY 
Languages Spoken:
English
Offers Telehealth

Jeffrey Bruce is a Neurosurgery provider in New York, New York. Dr. Bruce is rated as an Elite provider by MediFind in the treatment of Glioblastoma. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Gamma Knife Radiosurgery, and Awake Craniotomy.

What is the outlook (prognosis) for Glioblastoma?
The prognosis for individuals with glioblastoma is poor. There is currently no cure for glioblastoma, and many people live less than a year after they're diagnosed. Individuals who've had a portion of their tumor removed, or individuals undergoing chemotherapy and radiation therapy are likely to experience longer survival. 
How do I prevent Glioblastoma?
There is no known way to prevent glioblastomas. However, if you develop any symptoms common to a glioblastoma, it is recommended to make an appointment with your doctor to be properly diagnosed.
What are the latest Glioblastoma Clinical Trials?
Randomized Phase II Trial of Anti-Lag-3 and Anti-PD-1 Blockade vs. SOC in Patients With Recurrent Glioblastoma

Summary: This phase II trial compares the safety, side effects and effectiveness of anti-lag-3 (relatlimab) and anti-PD-1 blockade (nivolumab) to standard of care lomustine for the treatment of patients with glioblastoma that has come back after a period of improvement (recurrent). Relatlimab is a monoclonal antibody that may interfere with the ability of tumor cells to grow and spread. A monoclonal antibo...

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Phase 2, Multicenter, Clinical Study to Evaluate the Efficacy and Safety of Safusidenib Erbumine in Patients With Isocitrate Dehydrogenase 1 (IDH1) Mutant Glioma

Summary: This is a 2-part study. The purpose of Part 1 of the study is to evaluate the efficacy, safety, and pharmacokinetic (PK) characteristics of safusidenib in participants with recurrent/progressive IDH1-mutant World Health Organization (WHO) Grade 2 or Grade 3 glioma. The purpose of Part 2 will be to evaluate the efficacy of maintenance safusidenib treatment versus placebo in IDH1-mutant Grade 3 astr...

What are some Advocacy Organizations?
keep-punching-brain-cancer

Keep Punching supports patients, healthcare providers, and researchers in their fight to prevent and eradicate brain cancer and minimize treatment-related side effects that may adversely impact function and comfort.